Medical Program: Understanding the Importance of RET Mutation as a Primary Oncogenic Driver

Understanding the Importance of RET Mutation as a Primary Oncogenic Driver

Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
RestartResume

The non-small cell lung cancer landscape is seeing the emergence of several genetic markers like RET fusion that may have therapies linked to them.

  • Overview

    When looking at the non-small cell lung cancer landscape, we’re now seeing the emergence of several genetic markers that may have therapies linked to them, and one of those markers is the RET fusion that exists. Join Dr. Edward Kim as he gets us caught up on the investigational therapies targeting RET-mutated non-small cell lung cancer that just might end up in the clinic.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free